In vitro susceptibility of filamentous fungi from mycotic keratitis to azole drugs

Journal de Mycologie Medicale

Volumn 25, Issue 1, 2015, Pages 44-49

  Shobana, C S ^a   Mythili, A ^a   Homa, M ^b   Galgoczy L ^b   Priya, R ^a   Babu Singh, Y R ^a   Panneerselvam, K ^c   Vagvolgyi C ^b   Kredics, L ^b   Narendran, V ^d   Manikandan, P ^d,e  

^a Dr GR Damodaran College of Science   (India)

^b UNIVERSITY OF SZEGED   (Hungary)

^c MR Government Arts College   (India)

^d ARAVIND EYE HOSPITAL   (India)

^e MAJMAAH UNIVERSITY   (Saudi Arabia)

Author keywords

Antifungal susceptibility and azole drugs; Fungal isolates; Mycotic keratitis

Indexed keywords

CLOTRIMAZOLE; ECONAZOLE; ITRACONAZOLE; KETOCONAZOLE; PYRROLE; VORICONAZOLE; ANTIFUNGAL AGENT; PYRROLE DERIVATIVE;

ALTERNARIA; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLUS FLAVUS; BACTERIUM ISOLATE; BIPOLARIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CURVULARIA; DRUG COST; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; EXOPHIALA; EXSEROHILUM; FILAMENTOUS FUNGUS; FUNGAL STRAIN; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; FUSARIUM; HUMAN; IN VITRO STUDY; INDIA; KERATOMYCOSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ANTIFUNGAL RESISTANCE; COMPARATIVE STUDY; CORNEAL ULCER; DRUG EFFECTS; EYE INFECTIONS, FUNGAL; FUNGUS; ISOLATION AND PURIFICATION; KERATITIS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PROCEDURES;

ALTERNARIA; ASPERGILLUS FLAVUS; BIPOLARIS; CURVULARIA; EXOPHIALA; EXSEROHILUM; FUNGI; FUSARIUM;

ANTIFUNGAL AGENTS; AZOLES; CORNEAL ULCER; DRUG RESISTANCE, FUNGAL; EYE INFECTIONS, FUNGAL; FUNGI; HUMANS; ITRACONAZOLE; KERATITIS; KETOCONAZOLE; MICROBIAL SENSITIVITY TESTS;

EID: 84924437561     PISSN: 11565233     EISSN: 17730449     Source Type: Journal    
DOI: 10.1016/j.mycmed.2014.10.024     Document Type: Article

References (43)

1. Agarwal P.K., Roy P., Das A., Banerjee A., Maity P.K., Banerjee A.R. Efficacy of topical and systemic itraconazole as a broad-spectrum antifungal agent in mycotic corneal ulcer. A preliminary study. Indian J Ophthalmol 2001, 49:173-176.
2. Agrawal V., Biswas J., Madhavan H.N., Mangat G., Reddy M.K., Saini J.S., et al. Current perspectives in infectious keratitis. Indian J Opthalmol 1994, 42:171-192.
3. Akter L., Salam M.A., Hasan B., Begum N., Ahmed I. Etiological agents of suppurative corneal ulcer: study of 56 cases. Bangladesh J Med Microbiol 2009, 3:33-36.
4. Baginski M., Czub J. Amphotericin B and its new derivatives-mode of action. Current Drug Metab 2009, 10:459-469.
5. Bennett J.E. Diagnosis and treatment of fungal infections. Harrison's principles of International Medicine 1998, 1148-1154. McGraw-Hill, New York. A.S. Fauci, E. Braunwald, K.J. Isselbacher, J.D. Wilson, J.B. Martin, D.L. Kasper (Eds.).
6. Bharathi M.J., Ramakrishnan R., Vasu S., Meenakshi R., Palaniappan R. Epidemiological characteristics and laboratory diagnosis of fungal keratitis. A three-year study. Indian J Ophthalmol 2003, 51:315-321.
7. Bharathi M.J., Ramakrishnan R., Meenakshi R., Padmavathy S., Shivakumar C., Srinivasan M. Microbial keratitis in South India: influence of risk factors, climate, and geographical variation. Ophthalmic Epidemiol 2007, 14:61-69.
8. Bharathi M.J., Ramakrishnan R., Meenakshi R., Shivakumar C., Lional Raj D. Analysis of the risk factors predisposing to fungal, bacterial & Acanthamoeba keratitis in south India. Indian J Med Res 2009, 130:749-757.
9. Clinical Laboratory Standards Institute Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard 2008, Clinical and Laboratory Standards Institute, Wayne, PA, [CLSI document M38-A2]. 2nd ed.
10. Drummond L.J., McCoubrey J., Smith D.G., Starr J.M., Poxton I.R. Changes in sensitivity patterns to selected antibiotics in Clostridium difficile in geriatric in-patients over an 18-month period. J Med Microbiol 2003, 52:259-263.
11. Forster R.K., Rebell G., Wilson L.A. Dematiaceous fungal keratitis. Clinical isolates and management. Br J Ophthalmol 1975, 59:372-376.
12. Galarreta D.J., Tuft S.J., Ramsay A., Dart J.K. Fungal keratitis in London: microbiological and clinical evaluation. Cornea 2007, 26:1082-1086.
13. Gao H., Pennesi M., Shah K., Qiao X., Hariprasad S.M., Mieler W.F., et al. Intravitreal voriconazole: an electroretinographic and histopathologic study. Arch Ophthalmol 2004, 122:1687-1692.
14. Harris J.L. Safe, low-distortion tape touch method for fungal slide mounts. J Clin Microbiol 2000, 38:4683-4684.
15. Homa M., Shobana C.S., Singh Y.R.B., Manikandan P., Panneerselvam K., Kredics L., et al. Fusarium keratitis in South India: causative agents, their antifungal susceptibilities and a rapid identification method for the Fusarium solani species complex. Mycoses 2013, 56:501-511.
16. Houang E., Lam D., Fan D., Seal D. Microbial keratitis in Hong Kong: relationship to climate, environment and contact-lens disinfection. Trans R Soc Trop Med Hyg 2001, 95:361-367.
17. Iqbal N.J., Boey A., Park B.J., Brandt M.E. Determination of in vitro susceptibility of ocularFusariumspp. isolates from keratitis cases and comparison of Clinical and Laboratory Standards Institute M38-A2 and E test methods. Diagn Microbiol Infect Dis 2008, 62:348-350.
18. Jacob P., Gopinathan U., Sharma S., Rao G.N. Calcium alignate swab versus Bard Parker blade in the diagnosis of microbial keratitis. Cornea 1995, 14:360-364.
19. Lalitha P., Shapiro B.L., Srinivasan M., Prajna N.V., Acharya N.R., Fothergill A.W., et al. Antimicrobial susceptibility of Fusarium. Aspergillus, and other filamentous fungi isolated from keratitis. Arch Ophthalmol 2007, 125:789-793.
20. Lalitha P., Sun C.Q., Prajna N.V., Karpagam R., Geetha M., O'Brien K.S., et al. In vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial. Am J Ophthalmol 2014, 157:318-326.
21. Laniado-Laborin R., Cabrales-Vargas M.N. Amphotericin B: side effects and toxicity. Revista Iberoam Micol 2009, 26:223-227.
22. Leck A.K., Thomas P.A., Hagan M., Kaliamurthy J., Ackuaku E., John M., et al. Etiology of suppurative corneal ulcers in Ghana and south India, and epidemiology of fungal keratitis. Br J Ophthalmol 2002, 86:1211-1215.
23. Liesegang T.J., Forster R.K. Spectrum of microbial keratitis in South Florida. Am J Ophthalmol 1980, 90:38-47.
24. Manikandan P., Varga J., Kocsubé S., Anita R., Revathi R., Vágvölgyi C., et al. Epidemiology of Aspergillus keratitis at a tertiary care eye hospital in South India and antifungal susceptibilities of the causative agents. Mycoses 2013, 56:26-33.
25. Marangon F.B., Miller D., Giaconi J.A., Alfonso E.C. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens. Am J Ophthalmol 2004, 137:820-825.
26. Nehemy M.B., Vasconcelos-Santos D.V., Torqueti-Costa L., Magalhaes E.P. Chronic endophthalmitis due to Verticillium species after cataract surgery treated (or managed) with pars plana vitrectomy and oral and intravitreal voriconazole. Retina 2006, 26:225-227.
27. Norina T.J., Raihan S., Bakiah S., Ezanee M., Liza-Sharmini A.T., Wan Hazzabah W.H. Microbial keratitis: aetiological diagnosis and clinical features in patients admitted to Hospital Universiti Sains Malaysia. Singapore Med J 2008, 49:67-71.
28. O'Day D.M. Fungal keratitis. Ocular infections and immunity 1997, 263-264. Mosby, St Louis. J.S. Pepose, G.N. Holland, K.R. Wilhemus (Eds.).
29. O'Day D.M., Head W.S., Robinson R.D., Clanton J.A. Corneal penetration of topical amphotericin B and natamycin. Curr Eye Res 1986, 5:877-882.
30. Pfaller M.A., Messer S.A., Hollis R.J., Jones R.N., Diekema D.J. In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6970 clinical isolates of Candida spp. Antimicrob Agents Chemother 2002, 46:1723-1727.
31. Prajna N.V., Krishnan T., Mascarenhas J., Rajaraman R., Prajna L., Srinivasan M., et al. The mycotic ulcer treatment trial: randomized trial comparing natamycin vs voriconazole. JAMA Ophthalmol 2013, 131:422-429.
32. Pujol I., Guarro J., Gené J., Sala J. In vitro antifungal susceptibility of clinical and environmental Fusarium spp. strains. J Antimicrob Chemother 1997, 39:163-167.
33. Rosa R.H., Miller D., Alfonso E.C. The changing spectrum of fungal keratitis in south Florida. Ophthalmology 1994, 101:1005-1013.
34. Sirikul T., Prabriputaloong T., Smathivat A., Chuck R.S., Vongthongsri A. Predisposing factors and etiologic diagnosis of ulcerative keratitis. Cornea 2008, 27:283-287.
35. Srinivasan M. Fungal keratitis. Curr Opin Ophthalmol 2004, 15:321-327.
36. Srinivasan M., Gonzales C.A., George C., Cevallos V., Mascarenhas J.M., Asokan B., et al. Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, South India. Br J Ophthalmol 1997, 81:965-971.
37. Srinivasan M., Gonzales C.A., George C., Cevallos V., Mascarenhas J.M., Asokan B., et al. Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, south India. Br J Ophthalmol 1997, 81:965-971.
38. Stanzani M., Tumietto F., Vianelli N., Baccarani M. Uptate on the treatment of disseminated fusariosis: Focus on voriconazole. Ther Clin Risk Manag 2007, 3:1165-1173.
39. Thomas P.A. Mycotic keratitis-an underestimated mycosis. J Med Vet Mycol 1994, 32:235-256.
40. Thomas P.A. Current perspectives on ophthalmic mycoses. Clin Microbiobiol Rev 2003, 16:730-797.
41. Tilak R., Singh A., Maurya O.P., Chandra A., Tilak V., Gulati A.K. Mycotic keratitis in India: a five-year retrospective study. J Infect Dev Ctries 2010, 4:171-174.
42. Whitcher J.P., Srinivasan M., Upadhyay M.P. Microbial keratitis. The epidemiology of eye diseases 2003, 190-195. Arnold, London. 2nd ed. G.J. Johnson, D.C. Minassian, R.A. Weale, S.K. West (Eds.).
43. Xie L., Zhai H., Zhao J., Sun S., Shi W., Dong X. Antifungal susceptibility for common pathogens of fungal keratitis in Shandong Province, China. Am J Ophthalmol 2008, 146:260-265.